The dawn of cardioprotection by infarct size reduction originated from the idea to favourably
alter the oxygen demand–supply balance of the ischaemic/infarcting myocardium by …

Cardiocerebrovascular diseases (CCVDs) are the leading cause of death worldwide;
therefore, to deeply explore the pathogenesis of CCVDs and to find the cheap and efficient …

Summary Background Argon (Ar) has been proposed as a potential therapeutic agent in
multiple clinical conditions, specifically in organ protection. However, conflicting data on pre …

The objective of this study was to explore the effect of argon preconditioning on myocardial
ischemia reperfusion (MI/R) injury and its mechanism. Cardiomyocytes H2C9 were pre …

We studied the effect of 2-h inhalation of argon-oxygen mixture (Ar 70%/O2 30%) after
photochemically induced stroke and on days 2 and 3 after stroke modeling on the severity of …

Background Ventilation with the noble gas argon (Ar) has shown neuroprotective and
cardioprotective properties in different in vitro and in vivo models. Hence, the …

While it is well-known that pre-stroke exercise conditioning reduces the incidence of stroke
and the development of comorbidities, it is unclear whether post-stroke exercise …

The noble gas argon (Ar) is a “biologically” active element and has been extensively studied
preclinically for its organ protection properties. This work reviews all preclinical studies …

Purpose: Doxorubicin (DOX) is a widely used chemotherapeutic agent complicated with
cardiotoxic adverse effects. Up till now, there are no researches discussing the role of …

The aim of the study was to assess the effect of external use of inert gases (helium and
argon) on the state of free radical processes in vivo. The experiment was performed on 30 …